“What’s next in multiple myeloma?”
Catania, September 23,2019
Aula CAST
A.O.U. Policlinico Universitario
“Gaspare Rodolico”
Via Santa Sofia, 78 - Catania
Scientific Board: F. Di Raimondo - G. A. Palumbo
Monday,
September 23, 2019
08:30
Registration of Participants
Introduction
Francesco Di Raimondo (Catania)
I SESSION
NOVEL
INSIGHTS IN CLINICAL MANAGEMENT OF MYELOMA PATIENTS
Chairmen: Maurizio Musso (Palermo), Caterina Musolino
(Messina)
09:00
Up-front
treatment in myeloma patients in 2019
Alessandro Corso (Pavia)
09:20
Treatment of relapsing/refractory
patients
Massimo Offidani
(Ancona)
09:40
Strategies for relapses beyond the 2nd line: patient profiling
Marco Rossi (Catanzaro)
10:00
Immunotherapy in multiple
myeloma
Massimo
Massaia (Cuneo)
10:20
Discussion on
previous sessions
10:30
Coffee Break
II
SESSION
Novel insights in Myeloma biology
Chairmen:
Donato Mannina (Messina), Sergio Siragusa (Palermo)
11:00
Non-neutral clonal evolution in Multiple Myeloma
Carolina
Terragna (Bologna)
11:20
Non-coding genomic aberrations in Multiple Myeloma
Antonino
Neri (Milano)
11:40
Role of microenvironment dysfunction in
promoting Multiple Myeloma
Angelo Vacca (Bari)
12:00
Epigenetics in multiple myeloma"?
Aldo Roccaro (Brescia)
12:20
Modelling myeloma to predict clinical outcome by systems thinking
Francesco Gonella, Alessandra Romano (Venezia, Catania)
12:50
Discussion on previous sessions
13:10
Light Lunch
Novel insights in Myeloma diagnosis and prognosis
Chairmen: Pellegrino Musto (Rionero in Vulture), Ugo Consoli (Catania)
14:10
The
role of FISH in the management of multiple
myeloma
Paola Omedè (Torino)
14:30
The role of next-generation sequencing in
the management of multiple myeloma
Niccolò
Bolli (Milano)
14:50
Minimal residue
disease: how and when to detect?
Bruno Paiva (Pamplona)
15:10
A
network experience in lymphoproliferative
diseases: the case of BCL-2 monitoring
Marco Ladetto (Alessandria)
15.30
The
Sicilian Myeloma Network experience
Etta Conticello (Catania)
15,40
How to deal with
the sustainability of the new drugs costs
Federico Spandonaro (Roma)
15:50
Discussion on
previous sessions
16:00
Coffee break
16:15-17:30 Interactive session
Participants will be divided
in four groups
GROUP A:
Immunophenotyping in
myeloma: circulating plasma cells and minimal residual disease
Tutor
Laura Parrinello (Catania)
GROUP B:
Immune cells in multiple myeloma: MDSC and T-cell
sub-populations
Tutor
Ciro Botta (Catanzaro)
GROUP C:
CD138+ cells enrichment
and molecular assays
Tutor
Daniele Tibullo (Catania)
GROUP D:
Ethical and
administrative requirements for multicentric trials
Tutor Vittorio Del Fabro and Marco Ragusa (Catania)
16.30
Test ECM and Conclusion
